ELECTREON
9.3.2022 09:02:12 CET | Business Wire | Press release
Electreon intends to enter the Finnish market through a collaboration with Destia, the biggest infrastructure service company and a leading provider of charging infrastructure services in Finland. The companies have signed a Memorandum of Understanding (MoU) and as part of the collaboration, the companies will first showcase the wireless charging solution to potential customers by integrating the Electreon wireless system to a commercial electric vehicle (EV). This will give fleet operators the opportunity to experience the benefits of wireless charging in operation.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220309005236/en/
The goal of the collaboration is to develop commercial wireless charging projects, where Electreon’s wireless charging system and related operation and maintenance services could be provided as part of Destia’s Charging as a Service solution. Destia offers EV charging solutions for businesses and professional transport, its customers include bus operators, logistics companies, vehicle manufacturers and taxi companies.
Both companies see great potential for wireless charging and wireless Electric Road System (ERS) projects in Finland for different use cases such as buses, delivery trucks, vans, and taxis. ERS deployments can help decrease greenhouse gas emissions from the transport sector and create conditions for electric vehicle commercialization.
This MoU is part of Electreon’s strategy to accelerate its penetration to the Nordic market which has a huge potential as an early adopter of electric mobility. Maher Kasskawo, an e-mobility specialist from one of the Nordic region’s leading public transport operators, has recently joined Electreon as the Nordics business development manager to head the company’s efforts. Mr. Kasskawo has multiple years of experience of Nordic e-bus and charging systems implementation and operation.
“We are very excited to establish the partnership between Destia and Electreon in the Finnish market. Combining Destia’s strength in charging infrastructure and services with Electreon’s seamless technology in both static and dynamic wireless charging will be a competitive solution for many operational businesses within the transportation segment,” says Maher Kasskawo, Business Development Manager, Electreon.
“Wireless charging has great potential especially in the professional transport segment, because it can be fully integrated into infrastructure with no visual impacts and cables. Electreon’s wireless charging technology can complement our EV Charging as a Service solution nicely,” says Jere Jokinen, Head of EV Charging at Destia.
About Electreon
Electreon is the leading provider of wireless charging solutions for electric vehicles (EVs), providing end-to-end charging infrastructure and services to meet the needs and efficiency demands of shared, public and commercial fleet operators and consumers. The company’s proprietary inductive technology dynamically (while in motion) and statically (while stopped) charges EVs quickly and safely, eliminating range anxiety, lowering total costs of EV ownership, and reducing battery capacity needs—making it one of the most environmentally sustainable, scalable, and compelling charging solutions available today. Electreon works with cities and fleet operators on a charging as a service (CaaS) platform that enables cost-effective electrification of public, commercial, and autonomous fleets for smooth and continuous operation. For more information, visit electreon.com .
About Destia
Destia is the biggest infrastructure service company in Finland. Our services cover the entire infrastructure life cycle from design to construction and maintenance. We create urban construction innovations and smart infrastructure solutions that facilitate the movement of people, goods, services and energy as part of northern life. We build tomorrow’s infrastructure with the unique sense of infrastructure of more than 1,600 professionals. Destia’s revenue amounted to approximately MEUR 565 in 2020. Destia is part of the international Colas Group.www.destia.fi/en/
View source version on businesswire.com: https://www.businesswire.com/news/home/20220309005236/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Alsym Energy Announces Na-Series Battery Success Developed With Physics-Informed AI Platform27.4.2026 21:25:00 CEST | Press release
Alsym’s proprietary physics-informed AI platform powered the development of its Na-Series batteries—a non-flammable, high performance and low cost energy solution positioned to serve critical energy storage markets including data centers, utilities, telecommunications, commercial real estate, industrial and defense, among others. Alsym Energy, a pioneer in non-flammable, high-performance sodium-ion batteries, today announced details of the proprietary physics-informed AI platform used to develop the company’s recently launched Na-Series sodium-ion batteries. By integrating fundamental physics models with AI, autonomous testing and proprietary molecular diagnostics in a closed-loop system, Alsym is accelerating the design of safer, inexpensive, commercialized batteries through all phases of the development cycle. As global demand for electricity surges, the limitations of lithium-ion batteries have become increasingly apparent, particularly around safety and supply chain constraints. Li
Backed by Investments Exceeding $1 Billion, PCI Pharma Services Announces Major Expansion of US Sterile Fill-Finish and Drug-Device Delivery Combination Capabilities27.4.2026 16:00:00 CEST | Press release
As pharma manufacturers prioritize US supply chain resilience, highlights include high-speed isolator filling lines for prefilled syringes, cartridges and vials, and drug-device combination assembly and packaging. PCI Pharma Services (“PCI”) – a world-leading integrated global contract development and manufacturing organization (CDMO) focused on innovative biologic and small molecule therapies – announced a series of major infrastructure investments that substantially deepen its sterile fill-finish and advanced drug delivery capabilities. As pharma manufacturers and their development partners increasingly prioritize US supply chain resilience, PCI’s latest investments come as part of a broader commitment exceeding $1 billion across the CDMO’s US and European operations, reinforcing its ability to provide seamless support for drug product development and manufacturing, clinical trial supply and drug-device combination assembly from clinical stages through commercial launch – all underpi
Pure Lithium Appoints Renowned Battery Expert Dr. Yuan Gao to Board of Directors27.4.2026 15:53:00 CEST | Press release
Pure Lithium Corporation, a vertically integrated lithium metal battery technology company, is pleased to announce that world-renowned inventor and battery expert Dr. Yuan Gao has joined the company’s Board of Directors. Dr. Gao has been an invaluable member of Pure Lithium’s Scientific Advisory Board since October of 2023. "We are thrilled to have Dr. Gao join our board as we focus on rapidly scaling our technology in the most capital efficient manner possible,” said Pure Lithium Founder, Chairman and CEO Emilie Bodoin. “Dr. Gao is a brilliant scientist who also has deep commercial expertise, a rare combination. He is also unique in the industry because his experience spans the entire battery materials value chain, including all of Pure Lithium’s verticals. His insights over the years have been critical in advancing our technology, and his experience as a director of public companies will strengthen our board.” Dr. Gao commented: “I am thrilled to join the board of Pure Lithium Corpor
Taiho Oncology, Taiho Pharmaceutical and Araris Biotech AG Advance ADC ARC-02 into Phase 1 Clinical Development27.4.2026 15:00:00 CEST | Press release
Phase 1 dose-escalation trial represents the first clinical trial of a product developed using the AraLinQ™ ADC technology and marks Taiho’s expansion into the clinical development of ADCs for oncology Taiho Oncology, Inc., Taiho Pharmaceutical Co., Ltd., and Araris Biotech AG (“Araris”) today announced that the U.S. Food and Drug Administration (FDA) has completed its Investigational New Drug (IND) review period for ARC-02, an antibody-drug conjugate (ADC) being developed for the treatment of non-Hodgkin lymphoma, enabling Taiho Oncology to initiate a Phase 1 dose-escalation clinical trial of ARC-02. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427127507/en/ Taiho Pharmaceutical acquired Araris Biotech in March 2025, expanding Taiho group’s capabilities in biologics and ADC research and development. Araris is a spin-off of the Paul Scherrer Institute and ETH in Switzerland focused on the development of antibody-drug co
Boomi To Unveil the Future Of Data Activation and AI-Driven Innovation at Boomi World 202627.4.2026 15:00:00 CEST | Press release
Premier global event to highlight how organizations are bringing data to life to power everything from AI to BI Boomi, the data activation company, today announced Boomi World 2026, its premier annual user conference, taking place May 11 - 14, 2026 in Chicago, IL. The event will bring together customers, partners, and industry leaders from around the world to explore how data activation is transforming the enterprise and accelerating the path to AI-driven outcomes. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427600340/en/ Boomi To Unveil the Future Of Data Activation and AI-Driven Innovation at Boomi World 2026 Boomi World 2026 will spotlight data activation — bringing data to life to power AI, analytics, and intelligent automation. Attendees will gain firsthand insights into how the Boomi Enterprise Platform enables businesses to unify data, streamline operations, and innovate faster in an increasingly agentic world.
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom